Pair the pathways, then keep the paperwork
A stack pairs sequences that call different receptors, instead of raising the concentration of one compound and hoping a second pathway appears. Blends such as GLOW share one cake. Bundles such as the BPC-157 and TB-500 10mg set keep each cake sealed. NAD+ stays in its own vial beside MOTS-c. Browse peptide bundles and stacks when you want the sets already matched.
Tissue & Joint Recovery: Why BPC-157 & TB-500 Are Paired ("The Wolverine Stack")
BPC-157 is studied for cellular migration and angiogenic signalling, including VEGF-linked readouts in published models. TB-500, a thymosin beta-4 fragment, is studied for actin handling and cell movement. People pair them because those pathways are not copies of each other, and UK buyers nicknamed that pair the Wolverine stack.
The nickname is affectionate catalogue speech for a pairing, not a third molecule, and it is a good way to remember why the two belong together. BPC-157 is the fifteen-amino-acid peptide in the migration and angiogenic assays. TB-500 is the actin-handling fragment. Raising the concentration of one of them does not recruit the other pathway, which is the whole point of pairing them. You can buy that idea as one shared cake or as two sealed vials, and each batch still has its own paperwork.
The 1:1 blend is one cake. The 5mg bundle and the 10mg bundle stay as separate vials in tissue and recovery. Open View COA on each page before you compare them.
Skin Elasticity, Collagen & Renewal: Inside the GLOW (70mg) & KLOW (80mg) Blends
GLOW places GHK-Cu, BPC-157, and TB-500 in one 70mg cake for matrix, migration, and actin questions studied together. KLOW adds KPV in an 80mg cake. A bundle is different, because those names can arrive as separate vials, and each cake stays sealed until you mix it.
If collagen and matrix work is what drew you in, this is the blend people open first, and it helps to know what is actually in the cake. GLOW 70mg combines GHK-Cu, BPC-157, and TB-500. The copper tripeptide is the matrix and collagen sequence. BPC-157 and TB-500 bring the migration and actin questions from the recovery pair. KLOW 80mg adds KPV, the short alpha-MSH sequence studied in innate-immune cell models. Adding KPV is why KLOW is not just a larger GLOW.
The GLOW bundle is BPC-157 10mg, TB-500 10mg, and GHK-Cu 50mg as separate vials, which suits you if you want to mix each cake on its own day. Skin and copper peptides also lists GHK-Cu alone, with the same >= 99.0 percent HPLC standard and the same two documents.
Cellular Energy & Healthy Ageing: Why NAD+, MOTS-c & SS-31 Work Together (And Why NAD+ Stays in Its Own Vial)
NAD+, MOTS-c, and SS-31 are studied together because they touch mitochondrial energy from different directions. NAD+ is a redox cofactor weighed in hundreds of milligrams. MOTS-c and SS-31 are short peptides. One shared cake would blur the masses, so NAD+ stays in its own vial.
Yes, they are studied side by side, and no, they are not packed as one powder. NAD+ is sold at 250mg, 500mg, and 1000mg because it is a redox cofactor, not a 5mg signalling fragment. MOTS-c is the short mitochondrial peptide studied in AMPK-linked assays. Putting the cofactor into the peptide cake would swamp the peptide mass and make either concentration hard to state. That is why the vials stay separate even when the model runs both, and it is a sign of a careful catalogue rather than a missing blend.
SS-31 is studied for cardiolipin association in the inner mitochondrial membrane. The Mito bundle pairs it with MOTS-c and NAD+. Mito Prime pairs NAD+, MOTS-c, and 5-Amino-1MQ. Both sit in longevity and mitochondrial peptides as separate vials.
Growth Factor Pulse Synergy: Pairing CJC-1295 or Tesamorelin with Ipamorelin
CJC-1295 without DAC, and Tesamorelin, are studied as growth-hormone-releasing hormone receptor ligands. Ipamorelin is studied as a selective secretagogue at GHS-R1a. The pair lets a model watch two signals. Raising one concentration does not switch the second receptor on.
This is the pulse pair people ask for when they want both signals without mixing the cakes. CJC-1295 without DAC and Tesamorelin are the GHRH-receptor sequences. Ipamorelin is the GHS-R1a partner. They are complementary because the receptors are not the same, so each vial is mixed on its own and the paperwork stays attached to its own batch. The Tesamorelin and Ipamorelin bundle ships that pair as two vials, and the secretagogue category lists each sequence alone as well.
Endocrine & Melanocortin Signalling: Kisspeptin-10 & PT-141
Kisspeptin-10 is studied at KISS1R, upstream of GnRH. PT-141 is studied on melanocortin receptors, including MC4R. The pathways are not the same, which is why the pair is interesting, and why the bundle keeps the two cakes apart rather than raising the concentration of either one.
These two get mentioned together because the receptors differ, not because they are the same signal twice. Kisspeptin-10 is the KISS1R sequence. PT-141 is the melanocortin sequence. The Kisspeptin and PT-141 bundle keeps both cakes sealed, so you mix each one on its own and each file stays honest. The endocrine and melanocortin category lists each sequence alone as well. Confirm each file in the COA library, and check Sections S0 and S2 before tested competition.
Which peptides can share a vial, and which stay separate
| Combination | Same vial? | Why | Catalogue |
|---|---|---|---|
| BPC-157 + TB-500 blend | Yes, one cake | Manufactured 1:1 blend. Mix with bacteriostatic reconstitution solution. | Blend |
| BPC-157 and TB-500 bundles | No, separate vials | 5mg set and 10mg set. Each cake stays sealed until it is mixed. | 5mg bundle · 10mg bundle |
| GLOW 70mg | Yes, one cake | GHK-Cu, BPC-157, and TB-500 in a single 70mg cake. | GLOW |
| KLOW 80mg | Yes, one cake | GLOW sequences plus KPV in a single 80mg cake. | KLOW |
| GLOW bundle | No, separate vials | BPC-157, TB-500, and GHK-Cu each keep their own cake. | GLOW bundle |
| NAD+ with MOTS-c | No, separate vials | NAD+ is 250mg to 1000mg. MOTS-c stays in its own vial. SS-31 and 5-Amino-1MQ stay separate too. | Mito bundle · Mito Prime |
| CJC-1295 no DAC or Tesamorelin + Ipamorelin | No, separate vials | GHRH-receptor sequence and GHS-R1a sequence are mixed on their own. | Pulse bundle · CJC-1295 |
| Kisspeptin-10 + PT-141 | No, separate vials | KISS1R and MC4R are different pathways. The bundle keeps both cakes sealed. | Endocrine bundle |
| IGF-1 LR3 | Own vial only | Product page names 0.6 percent acetic acid, not the benzyl alcohol vehicle. | IGF-1 LR3 · 0.6% acetic acid |
| Most other sequences | Own vial | Bacteriostatic reconstitution solution, 0.9 percent benzyl alcohol, unless the page names another liquid. | Reconstitution solution |
Frequently Asked Questions
Primary sources
These are the primary documents. Statute short titles are given here so the citation matches the instrument a reader opens.